{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T15:06:40Z","timestamp":1782572800295,"version":"3.54.5"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.anl.2024.10.015","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T21:11:18Z","timestamp":1730409078000},"page":"1060-1067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of 1.5% levofloxacin otic solution in treating acute otitis externa: A post hoc analysis of ENT103-3001, a multicenter randomized double-blind parallel-group placebo-controlled phase III study in otitis media with persistent otorrhea"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7503-0872","authenticated-orcid":false,"given":"Han","family":"Matsuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6929-5084","authenticated-orcid":false,"given":"Tetsuo","family":"Ikezono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2024.10.015_bib0001","doi-asserted-by":"crossref","first-page":"87","DOI":"10.7883\/yoken.JJID.2020.499","article-title":"Japan Nosocomial Infections Surveillance (JANIS): current status, international collaboration, and future directions for a comprehensive antimicrobial resistance surveillance system","volume":"74","author":"Kajihara","year":"2021","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.anl.2024.10.015_bib0002","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0732-8893(00)00147-4","article-title":"In vitro characterization of fluoroquinolone concentration\/MIC antimicrobial activity and resistance while simulating clinical pharmacokinetics of levofloxacin, ofloxacin, or ciprofloxacin against Streptococcus pneumoniae","volume":"37","author":"Madaras-Kelly","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.anl.2024.10.015_bib0003","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.anl.2022.12.013","article-title":"Efficacy and safety of 1.5% levofloxacin otic solution for the treatment of otitis media in a multicenter, randomized, double-blind, parallel-group, placebo-controlled, phase III study","volume":"50","author":"Takahashi","year":"2023","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2024.10.015_bib0004","series-title":"Performance standards for antimicrobial susceptibility testing, CLSI document M100","year":"2021"},{"key":"10.1016\/j.anl.2024.10.015_bib0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1177\/0194599813514365","article-title":"Clinical practice guideline: acute otitis externa","volume":"150","author":"Rosenfeld","year":"2014","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2024.10.015_bib0006","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/0003489419830116","article-title":"OTO-201 for the treatment of acute otitis externa: results from a phase 3 randomized clinical study","volume":"128","author":"Ansley","year":"2019","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.anl.2024.10.015_bib0007","first-page":"18","article-title":"The treatment of chronic suppurative otitis media and otitis externa with 0.3 per cent ofloxacin otic solution: a clinico-microbiological study","volume":"78","author":"Supiyaphun","year":"1995","journal-title":"J Med Assoc Thail"},{"key":"10.1016\/j.anl.2024.10.015_bib0008","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/archotol.1997.01900110047007","article-title":"Ofloxacin otic solution for treatment of otitis externa in children and adults","volume":"123","author":"Jones","year":"1997","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2024.10.015_bib0009","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/ajot.2002.123461","article-title":"The use of otic powder in the treatment of acute external otitis","volume":"23","author":"Goldenberg","year":"2002","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.anl.2024.10.015_bib0010","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0149-2918(04)90176-2","article-title":"Efficacy of ofloxacin otic solution once daily for 7 days in the treatment of otitis externa: a multicenter, open-label, phase III trial","volume":"26","author":"Torum","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.anl.2024.10.015_bib0011","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00007611-200405000-00010","article-title":"Declining susceptibility to neomycin and polymyxin B of pathogens recovered in otitis externa clinical trials","volume":"97","author":"Cantrell","year":"2004","journal-title":"South Med J"},{"key":"10.1016\/j.anl.2024.10.015_bib0012","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1185\/030079906X121057","volume":"22","author":"Schwartz","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.anl.2024.10.015_bib0013","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.amjoto.2007.09.002","article-title":"A single topical agent is clinically equivalent to the combination of topical and oral antibiotic treatment for otitis externa","volume":"29","author":"Roland","year":"2008","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.anl.2024.10.015_bib0014","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1185\/03007990802583845","article-title":"Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa","volume":"24","author":"Drehobl","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.anl.2024.10.015_bib0015","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.otohns.2010.06.819","article-title":"Comparison of safety and efficacy of foam-based versus solution-based ciprofloxacin for acute otitis externa","volume":"143","author":"Marom","year":"2010","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2024.10.015_bib0016","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.21699","article-title":"Efficacy and safety of ciprofloxacin plus fluocinolone acetonide among patients with acute otitis externa: a randomized clinical trial","volume":"5","author":"Chu","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.anl.2024.10.015_bib0017","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.otohns.2006.02.013","article-title":"Systematic review of topical antimicrobial therapy for acute otitis externa","volume":"134","author":"Rosenfeld","year":"2006","journal-title":"Otolaryngol Head Neck Surg"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814624001354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814624001354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T11:56:48Z","timestamp":1734695808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814624001354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0385814624001354"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2024.10.015","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of 1.5% levofloxacin otic solution in treating acute otitis externa: A post hoc analysis of ENT103-3001, a multicenter randomized double-blind parallel-group placebo-controlled phase III study in otitis media with persistent otorrhea","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2024.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}